RIGL

Fostamatinib Selected for NIH ACTIV-4 COVID-19 Clinical Trial

Rigel Pharmaceuticals: A Patented FDA Approved Drug That May Successfully Fight COVID-19

Rigel to Present at the Jefferies Virtual Healthcare Conference

Rigel Appoints Alison L. Hannah, M.D.

RIGL Stock: 11.82% Increase (From $3.47 To $3.88) Pre-Market Explanation

Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q1 2021 Results - Earnings Call Transcript

Rigel Pharmaceuticals (RIGL) Tops Q1 Earnings and Revenue Estimates